Sunil Patel - Net Worth and Insider Trading
Sunil Patel Net Worth
The estimated net worth of Sunil Patel is at least $3 Million dollars as of 2024-04-27. Sunil Patel is the Director of Ligand Pharmaceuticals Inc and owns about 28,190 shares of Ligand Pharmaceuticals Inc (LGND) stock worth over $2 Million. Sunil Patel is the Director of OmniAb Inc and owns about 215,512 shares of OmniAb Inc (OABI) stock worth over $965,494. Sunil Patel is also the See Remarks of OncoMed Pharmaceuticals Inc and owns about 68,336 shares of OncoMed Pharmaceuticals Inc (OMED) stock worth over $60,819. Details can be seen in Sunil Patel's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Sunil Patel has not made any transactions after 2022-11-09 and currently still holds the listed stock(s).
Transaction Summary of Sunil Patel
Sunil Patel Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sunil Patel owns 4 companies in total, including Ligand Pharmaceuticals Inc (LGND) , OncoMed Pharmaceuticals Inc (OMED) , and Avista Public Acquisition Corp II (AHPA) among others .
Click here to see the complete history of Sunil Patel’s form 4 insider trades.
Insider Ownership Summary of Sunil Patel
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LGND | Ligand Pharmaceuticals Inc | 2020-11-02 | director |
| OMED | OncoMed Pharmaceuticals Inc | 2018-01-04 | See Remarks |
| AHPA | Avista Public Acquisition Corp II | 2022-11-01 | director |
| OABI | OmniAb Inc | 2022-11-09 | director |
Sunil Patel Latest Holdings Summary
Sunil Patel currently owns a total of 3 stocks. Among these stocks, Sunil Patel owns 28,190 shares of Ligand Pharmaceuticals Inc (LGND) as of November 2, 2020, with a value of $2 Million and a weighting of 65.97%. Sunil Patel owns 215,512 shares of OmniAb Inc (OABI) as of November 9, 2022, with a value of $965,494 and a weighting of 32.02%. Sunil Patel also owns 68,336 shares of OncoMed Pharmaceuticals Inc (OMED) as of October 10, 2017, with a value of $60,819 and a weighting of 2.02%.
Latest Holdings of Sunil Patel
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LGND | Ligand Pharmaceuticals Inc | 2020-11-02 | 28,190 | 70.57 | 1,989,368 |
| OABI | OmniAb Inc | 2022-11-09 | 215,512 | 4.48 | 965,494 |
| OMED | OncoMed Pharmaceuticals Inc | 2017-10-10 | 68,336 | 0.89 | 60,819 |
Holding Weightings of Sunil Patel
Sunil Patel Form 4 Trading Tracker
According to the SEC Form 4 filings, Sunil Patel has made a total of 2 transactions in Ligand Pharmaceuticals Inc (LGND) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Ligand Pharmaceuticals Inc is the acquisition of 1,000 shares on November 2, 2020, which cost Sunil Patel around $82,520.
According to the SEC Form 4 filings, Sunil Patel has made a total of 1 transactions in OmniAb Inc (OABI) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in OmniAb Inc is the acquisition of 43,000 shares on November 9, 2022, which cost Sunil Patel around $119,110.
According to the SEC Form 4 filings, Sunil Patel has made a total of 0 transactions in OncoMed Pharmaceuticals Inc (OMED) over the past 5 years. The most-recent trade in OncoMed Pharmaceuticals Inc is the sale of 1,248 shares on October 10, 2017, which brought Sunil Patel around $5,292.
Insider Trading History of Sunil Patel
- 1
Sunil Patel Trading Performance
GuruFocus tracks the stock performance after each of Sunil Patel's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Sunil Patel is 37.83%. GuruFocus also compares Sunil Patel's trading performance to market benchmark return within the same time period. The performance of stocks bought by Sunil Patel within 3 months outperforms 5 times out of 6 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Sunil Patel's insider trading performs compared to the benchmark.
Performance of Sunil Patel
Average Return
68.83%
Outperforming Transactions
100%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 15.13 | 37.83 | 35.41 | 68.83 | 60.84 | 51.98 |
| Relative Return to S&P 500(%) | 12.81 | 30.25 | 25.05 | 48.91 | 45.16 | 38.1 |
Sunil Patel Ownership Network
Ownership Network List of Sunil Patel
Ownership Network Relation of Sunil Patel
Sunil Patel Owned Company Details
What does Ligand Pharmaceuticals Inc do?
Who are the key executives at Ligand Pharmaceuticals Inc?
Sunil Patel is the director of Ligand Pharmaceuticals Inc. Other key executives at Ligand Pharmaceuticals Inc include Chief Financial Officer Octavio Espinoza , CHIEF LEGAL OFFICER & Andrew Reardon , and CEO & President John L Higgins .
Ligand Pharmaceuticals Inc (LGND) Insider Trades Summary
Over the past 18 months, Sunil Patel made no insider transaction in Ligand Pharmaceuticals Inc (LGND). Other recent insider transactions involving Ligand Pharmaceuticals Inc (LGND) include a net sale of 20,000 shares made by John L Higgins , a net sale of 10,852 shares made by John W Kozarich , and a net sale of 8,301 shares made by Stephen L Sabba .
In summary, during the past 3 months, insiders sold 2,033 shares of Ligand Pharmaceuticals Inc (LGND) in total and bought 0 shares, with a net sale of 2,033 shares. During the past 18 months, 41,289 shares of Ligand Pharmaceuticals Inc (LGND) were sold and 4,000 shares were bought by its insiders, resulting in a net sale of 37,289 shares.
Ligand Pharmaceuticals Inc (LGND)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ligand Pharmaceuticals Inc Insider Transactions
Sunil Patel Mailing Address
Above is the net worth, insider trading, and ownership report for Sunil Patel. You might contact Sunil Patel via mailing address: 11085 North Torrey Pines Rd., Suite 300, La Jolla Ca 92037.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
